News

«BioEq» recruits for healthy volunteers to participate in a bioequivalence trial.

«BioEq» recruits for patients to participate in a phase III clinical study in NSCLC

«BioEq» recruits for patients to participate in a phase III clinical study in sore throat(pharyngalgia) caused by acute infection of upper respiratory tract

«BioEq» recruits for patients with anemia caused by chronic renal disease to participate in a phase III clinical study

«BioEq» recruits for patients with steatohepatitis to participate in a clinical study.

«BioEq» 2017 achievements

World Cancer Day is celebrated annually on February, 4th. Each day «BioEq» helps oncology patients to fight cancer. We can, I can.

On December, 14, 2017, Dr. Polina Khlyabova, Director of Quality Department at «BioEq», took part in Quality Assurance forum as a speaker.

Merry Christmas and Happy New Year from «BioEq» team!

«BioEq» recruits for patients with non-small cells lung cancer to participate in a phase II clinical study.

«BioEq» recruits for patients with nonresectable or metastatic melanoma to participate in a phase II clinical study.

«BioEq» recruits for patients with nonresectable or metastatic melanoma to participate in a phase I clinical study.

«BioEq» team wishes Happy Volunteer Day!

«BioEq» team recruits for healthy volunteers to participate in bioequivalence clinical study

The «BioEq» recruits for healthy patients to participate in a phase I clinical study BCD-148 drug.

The «BioEq» team will take part in «Partnership in Clinical Trials, Europe» сonference, which will be held in Amsterdam on November 28-29.

The Company «BioEq» Hit the Top Five Most Demanded Dedicated Research Sites in 2017

The «BioEq» team is attending the partnering forum Life Science Invest in St. Petersburg, which is held on November 8-9.

«BioEq» company is going to take part in the Adam Smith Conference “Clinical trials in Russia 2017” On November 14-15, which is going to be in Moscow.

Clinical Research Center «BioEq» invites patients to participate in the phase III clinical study of the drug for treatment of patients with the level of triglycerides on empty stomach in diapason from 5,6 mmol/L to 22,6 mmol/L.

Clinical research center «BioEq» offers patients to participate in the phase I comparative research of the drug for treatment of rheumatoid arthritis of moderate of severe forms. «BioEq» invites patients with inadequate response to treatment with the TNF antagonists and receiving background treatment with methotrexate.

Clinical Research Center «BioEq» invites patients to participate in the phase III clinical study of the drug for treatment of patients with nonalcoholic fatty liver disease associated with metabolic syndrome.

The research site «BioEq» invites to participate in a clinical trial of the 3rd phase, according to original immune drug as the supporting treatment after chemotherapy among patients with widespread small-cell lung cancer.

The research site «BioEq» invites to participate in a clinical trial of the 3rd phase patients with the extended or spreading small-cell lung cancer with a high expression of DLL3.

The research site «BioEq» invites to participate in a clinical trial of the 3rd phase of сarboplatin and paciitaxel.

The «BioEq» company is planning to become a member of «A real way from scientific developments to medicines» conference in November 2, Moscow.

On December, 14 in Moscow «BioEq» will take part in «Euroasian Association of Ensuring Quality» forum.

«BioEq» took part in the largest international conference «CPhI Worldwide 2017», which took place in Frankfurt on 24-16 October, 2017.

At «BioEq», we strive to meet our clients’ requirements for predictable enrollment and quickest start-up and close-out of study activities.

On October 6, 2017 on the platform of the Congress center of I.M.Sechenov First Moscow State Medical University provided "Ist International Medical Investment Forum".

«BioEq» took part in the «Outsourcing in Clinical Trials, Southern California» conference, taken place in of San Diego on September 27-28, 2017.

«BioEq» participated in the conference «Outsourcing in Clinical Trials, New England» that took place on September 6-7 in Boston (Massachusetts, USA).

«BioEq» is going to attend European Society for Medical Oncology congress that takes place on September, 8-12 2017 in Madrid, Spain.

«BioEq» successfully passed an audit of a top 10 Pharma company as a Phase I and bioequivalence unit. No major findings were identified.

Svetlana Odintsova , the head of the oncological department of «BioEq», had successfully done her PhD thesis

We invite patients – males and females from 12 to 65 years with bronchial asthma.

«BioEq» team attended the 13th Congress of the European Association for clinical pharmacology and therapeutics (EACPT), which took place in Prague from 24 to 27 June.

«BioEq» is going to attend the American Diabetes Association (ADA) conference, the 77th Scientific Sessions

«BioEq» team is going to attend the international congress ASCO 2017, which takes placein Chicago (June, 2nd to June 6th), the annual congress brings together more than 30, 000 oncology specialists from around the world to discuss modern therapies, new therapies for cancer patients, and unresolved issues.

«BioEq» team attended the V Russian Conference with international participation "Current issues of preclinical and clinical trials of medicines, biomedical cellular products and clinical research of medical devices", which is held from June, 1st to June 2nd in St. Petersburg based on the FSBEI HE "The First St. Petersburg State Medical University named after Academician I.P.Pavlov ».

«BioEq» team is going to attend the conference DIA 2017 which is held from June, 18 to June, 22 in Chicago

«BioEq» team will take part in BIO International Convention held in San Diego, from June, 19 to June, 22 2017.

«BioEq» team attended the IV conference of the C-CT « Actual issues of organization of Clinical trials conduct and subsequent submission of results state registration and quality confirmation » which took place on April, 20 2017.

«BioEq» took part in a seminar «Bioavailability and bioequivalence research: Regulatory approaches of Russia and the EAEC», organized by LLC Exacte Labs

It is important to understand that there is no universal method for the treatment of allergies and it is always necessary to visit a doctor who can suggest the appropriate therapy after a detailed examination

In conclusion, we would like to state that site selection for early stage trials in oncology should begin with sites that are both competent and capable of enrolling appropriate patients, have good clinical practice facilities and procedures, and employ sufficient and available qualified staff

«BioEq» is going to attend IPhEB&CPhI Russia 2017 - the largest pharmaceutical exhibition in Russia, which is held in Moscow on 28-30 March 2017

«BioEq»’s team is going to attend the XXIV Russian National Congress «Man and Medicine»

«BioEq» recruits for patients with pulmonary disease to participate in a clinical trial

«BioEq» recruits for patients with liver disease to participate in a clinical trial

«BioEq» recruits for patients with lungs’ cancer to participate in a clinical trial

«BioEq» recruits for patients with bronchial asthma to participate in a clinical trial

«BioEq» recruits for patients with mammary cancer to participate in a clinical trial

«BioEq» recruits for patients with lungs cancer to participate in a phase III clinical study

«BioEq» performed a corporte party

«BioEq» recruits for healthy males to participate in a paid medical study

«BioEq» recruits for patients with osteoarthritis to participate in a clinical trial

«BioEq» recruits for patients with mammary cancer to participate in a clinical trial

«BioEq» will be represented by Business Development team, who will be keen to meet with pharmaceutical and biotech companies

Here you will find the results of our 2, 5 years performance.

«BioEq» recruits for patients with oncology to participate in clinical trials

«BioEq» recruits for patients with osteoarthritis to participate in a clinical trial

We invite patients - males and females from 18 to 75 years with rheumatoid arthritis

«BioEq» will be represented by Business Development team, who will be keen to meet with pharmaceutical and biotech companies to discuss phase I-III clinical trials in Russia

«BioEq» attended Clinical Trials 2016 Forum, which is a leading conference on clinical trials in Russia.

«BioEq» team attended "Life Sciences Invest" 2016

It is one of the biggest events that is able to attract plenty of professionals from international and local pharmaceutical companies and CROs

The patients shared that participation in such projects, being under the constant supervision of doctors has brought significant benefit to them

It is expected that the event will be attended by more than 1000 delegates who are representatives of companies, leading specialists and employees who make key decisions

«BioEq» recruits for patients with defeat of bone tissue caused by a malignant tumor to participate in clinical study.

In October, «BioEq» is initiating several new bioequivalence studies including two studies to evaluate the safety and pharmacokinetics profile of drugs used in CNS disorders treatment, two studies with anti-infectives, two trials with antiulcer drugs

The conference brings together leading pharmaceutical and biotechnology companies, academic institutions and companies active in the sector of business services

«BioEq» recruits for healthy females to participate in a phase III clinical study with a contraceptive

The participants addressed the most important aspects of pre-clinical tests and early phase clinical studies of medicinal products, discussed the high demand for knowledge of GMP, GLP, GCP standards for advanced testing of new medicinal drugs in the pharmaceutical industry

«BioEq» will be happy to meet potential clients and partners for future collaboration

«BioEq» team will attend The Innovative Drug R&D Forum and Clinical Trials Russia Forum on November 19-22.

«BioEq» team took part at the «Open Innovations» Forum 2014 which is held on October 14-16 in Moscow.

If you would like to find out more information on the progress of the 1st commercial clinical pharmacology unit in Russia, discuss the needs for your studies, or explore clinical research opportunities in Russia - contact us in order to arrange a meeting

The clinical team has extensive experience in phase I-IV clinical research of medicinal products, in different therapeutic areas

«BioEq» team attended the «RBK» conference 2014 and performance the report.

«BioEq» is launching several studies in the nearest time

«BioEq» team has announced an official opening of the unit on March 21, 2014.

On March 21, 2014 a new commercial R&D unit for early phase and bioequivalence trials will be opened in Saint-Petersburg.

The company provides a full spectrum of services and a sort of one-stop shop for clinical research and product development needs of the Russian and foreign pharmaceutical and biotechnology companies